164
D. Cabrera DeBuc et al.
141. M. Hammer, D. Schweitzer, E. Thamm, A. Kolb, Optical properties of ocular fundus tissues
determined by optical coherence tomography. Opt. Commun. 186(1–3), 149–153 (2000).
https://doi.org/10.1016/S0030-4018(00)01054-3
142. W. Gao, E. Tatrai, G.M. Somfai, D. Cabrera DeBuc, Assessing the performance of optical
properties determination of intraretinal layers in healthy normal and type 1 diabetic eyes using
optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 52(6), 3689 (2011)
143. L.J. Balcer, D.H. Miller, S.C. Reingold, J.A. Cohen, Vision and vision-related outcome measures in multiple sclerosis. Brain J. Neurol. 138, 11–27 (2015)
144. E. Gordon-Lipkin, B. Chodkowski, D.S. Reich, S.A. Smith, M. Pulicken, L.J. Balcer et al.,
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology
69(16), 1603–1609 (2007)
145. E. Grazioli, R. Zivadinov, B. Weinstock-Guttman, N. Lincoff, M. Baier, J.R. Wong et al.,
Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis.
J. Neurol. Sci. 268(1–2), 12–17 (2008)
146. X. Wang, Y. Jia, R. Spain, B. Potsaid, J.J. Liu, B. Baumann et al., Optical coherence
tomography angiography of optic nerve head and parafovea in multiple sclerosis. Br. J.
Ophthalmol. 98(10), 1368–1373 (2014). https://doi.org/10.1136/bjophthalmol-2013-30454
7. PubMed PMID: 24831719
147. F. Zipp, O. Aktas, The brain as a target of inflammation: common pathways link inflammatory
and neurodegenerative diseases. Trends Neurosci. 29(9), 518–527 (2006). https://doi.org/10.
1016/j.tins.2006.07.006. PubMed PMID: 16879881
148. H. Jiang, D. Cabrera DeBuc, S. Delgado, A. Tao, B. Lam, J. Wang, Quantification of macular
blood flow volume and microvascular network in multiple sclerosis (MS) (P2.264). Neurology
82(10 Supplement), P2.264 (2014)
149. H. Jiang, S. Delgado, J. Yuan, W. Yan, D. Cabrera DeBuc, B. Lam et al., Impairment of the
retinal nerve fiber integrity and blood flow velocity in multiple sclerosis (P5.224). Neurology
84(14 Supplement), P5.224 (2015)
150. H. Jiang, Y. Ye, D. Cabrera DeBuc, M. Shen, B.L. Lam, L. Ge et al., Spectral oximetry measured with ultra-high resolution optical coherence tomography in multiple sclerosis, in 38th
Annual North American Neuro-Ophthalmology Society (NANOS) Meeting, 11–16 February,
San Antonio, TX (2012) (poster presentation)
151. B.R. White, M.C. Pierce, N. Nassif, B. Cense, B.H. Park, G.J. Tearney et al., In vivo dynamic
human retinal blood flow imaging using ultra-high-speed spectral domain optical Doppler
tomography. Opt. Express 11(25), 3490–3497 (2003). https://doi.org/10.1364/oe.11.003490.
PubMed PMID: WOS:000187324900021
152. P.K. Stys, G.W. Zamponi, J. van Minnen, J.J. Geurts, Will the real multiple sclerosis
please stand up? Nat. Rev. Neurosci. 13(7), 507–514 (2012). https://doi.org/10.1038/nrn3
275. PubMed PMID: 22714021
153. B. Braaf, K.A. Vermeer, K.V. Vienola, J.F. de Boer, Angiography of the retina and the
choroid with phase-resolved OCT using interval-optimized backstitched B-scans. Opt.
Express 20(18), 20516–20534 (2012). https://doi.org/10.1364/oe.20.020516. PubMed PMID:
WOS:000308414800087
154. T.D. France, Evidence-based guidelines for amblyogenic risk factors. Am. Orthopt. J. 56,
7–14 (2006)
155. P.A. Graham, Epidemiology of strabismus. Br. J. Ophthalmol. 58, 224–231 (1974)
156. L. Kiorpes, S.P. McKee, Neural mechanisms underlying amblyopia. Curr. Opin. Neurobiol.
9, 480–486 (1999)
157. G. Roper-Hall, Current concepts of amblyopia: a neuro-ophthalmology perspective. Am.
Orthopt. J. 57, 2–11 (2007)
158. G.K. Noorden, Mechanisms of amblyopia. Adv. Ophthalmol. 34, 93–115 (1977)
159. G.K. Noorden, M.L. Crawford, The lateral geniculate nucleus in human strabismic amblyopia.
Invest. Ophthalmol. Vis. Sci. 33, 2729–2732 (1992)
160. G.K. Noorden, M.L. Crawford, R.A. Levacy, The lateral geniculate nucleus in human anisometropic amblyopia. Invest. Ophthalmol. Vis. Sci. 24, 788–790 (1983)
D. Cabrera DeBuc et al.
141. M. Hammer, D. Schweitzer, E. Thamm, A. Kolb, Optical properties of ocular fundus tissues
determined by optical coherence tomography. Opt. Commun. 186(1–3), 149–153 (2000).
https://doi.org/10.1016/S0030-4018(00)01054-3
142. W. Gao, E. Tatrai, G.M. Somfai, D. Cabrera DeBuc, Assessing the performance of optical
properties determination of intraretinal layers in healthy normal and type 1 diabetic eyes using
optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 52(6), 3689 (2011)
143. L.J. Balcer, D.H. Miller, S.C. Reingold, J.A. Cohen, Vision and vision-related outcome measures in multiple sclerosis. Brain J. Neurol. 138, 11–27 (2015)
144. E. Gordon-Lipkin, B. Chodkowski, D.S. Reich, S.A. Smith, M. Pulicken, L.J. Balcer et al.,
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology
69(16), 1603–1609 (2007)
145. E. Grazioli, R. Zivadinov, B. Weinstock-Guttman, N. Lincoff, M. Baier, J.R. Wong et al.,
Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis.
J. Neurol. Sci. 268(1–2), 12–17 (2008)
146. X. Wang, Y. Jia, R. Spain, B. Potsaid, J.J. Liu, B. Baumann et al., Optical coherence
tomography angiography of optic nerve head and parafovea in multiple sclerosis. Br. J.
Ophthalmol. 98(10), 1368–1373 (2014). https://doi.org/10.1136/bjophthalmol-2013-30454
7. PubMed PMID: 24831719
147. F. Zipp, O. Aktas, The brain as a target of inflammation: common pathways link inflammatory
and neurodegenerative diseases. Trends Neurosci. 29(9), 518–527 (2006). https://doi.org/10.
1016/j.tins.2006.07.006. PubMed PMID: 16879881
148. H. Jiang, D. Cabrera DeBuc, S. Delgado, A. Tao, B. Lam, J. Wang, Quantification of macular
blood flow volume and microvascular network in multiple sclerosis (MS) (P2.264). Neurology
82(10 Supplement), P2.264 (2014)
149. H. Jiang, S. Delgado, J. Yuan, W. Yan, D. Cabrera DeBuc, B. Lam et al., Impairment of the
retinal nerve fiber integrity and blood flow velocity in multiple sclerosis (P5.224). Neurology
84(14 Supplement), P5.224 (2015)
150. H. Jiang, Y. Ye, D. Cabrera DeBuc, M. Shen, B.L. Lam, L. Ge et al., Spectral oximetry measured with ultra-high resolution optical coherence tomography in multiple sclerosis, in 38th
Annual North American Neuro-Ophthalmology Society (NANOS) Meeting, 11–16 February,
San Antonio, TX (2012) (poster presentation)
151. B.R. White, M.C. Pierce, N. Nassif, B. Cense, B.H. Park, G.J. Tearney et al., In vivo dynamic
human retinal blood flow imaging using ultra-high-speed spectral domain optical Doppler
tomography. Opt. Express 11(25), 3490–3497 (2003). https://doi.org/10.1364/oe.11.003490.
PubMed PMID: WOS:000187324900021
152. P.K. Stys, G.W. Zamponi, J. van Minnen, J.J. Geurts, Will the real multiple sclerosis
please stand up? Nat. Rev. Neurosci. 13(7), 507–514 (2012). https://doi.org/10.1038/nrn3
275. PubMed PMID: 22714021
153. B. Braaf, K.A. Vermeer, K.V. Vienola, J.F. de Boer, Angiography of the retina and the
choroid with phase-resolved OCT using interval-optimized backstitched B-scans. Opt.
Express 20(18), 20516–20534 (2012). https://doi.org/10.1364/oe.20.020516. PubMed PMID:
WOS:000308414800087
154. T.D. France, Evidence-based guidelines for amblyogenic risk factors. Am. Orthopt. J. 56,
7–14 (2006)
155. P.A. Graham, Epidemiology of strabismus. Br. J. Ophthalmol. 58, 224–231 (1974)
156. L. Kiorpes, S.P. McKee, Neural mechanisms underlying amblyopia. Curr. Opin. Neurobiol.
9, 480–486 (1999)
157. G. Roper-Hall, Current concepts of amblyopia: a neuro-ophthalmology perspective. Am.
Orthopt. J. 57, 2–11 (2007)
158. G.K. Noorden, Mechanisms of amblyopia. Adv. Ophthalmol. 34, 93–115 (1977)
159. G.K. Noorden, M.L. Crawford, The lateral geniculate nucleus in human strabismic amblyopia.
Invest. Ophthalmol. Vis. Sci. 33, 2729–2732 (1992)
160. G.K. Noorden, M.L. Crawford, R.A. Levacy, The lateral geniculate nucleus in human anisometropic amblyopia. Invest. Ophthalmol. Vis. Sci. 24, 788–790 (1983)